CHRS CapEx to Revenue

Coherus Oncology Inc · CapEx to Revenue

CHRS logo

CHRS CapEx to Revenue

Current (TTM)0.00%
CHRS CapEx/Revenue (93.89% → 0.00%)
High-resolution chart · PNG

CHRS capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0%
0%
0.1112%
0.9662%
0.3947%
1.5197%
3.622%
50.7069%
293.8946%
3.427%
20.5186%
9.159%
13.5587%
93.8915%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.